RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis

Abstract Somatic and germline gain‐of‐function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor‐prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss‐of‐function of the...

Full description

Bibliographic Details
Main Authors: Samantha Wong, Yu Xuan Tan, Abigail Yi Ting Loh, Kiat Yi Tan, Hane Lee, Zainab Aziz, Stanley F Nelson, Engin Özkan, Hülya Kayserili, Nathalie Escande‐Beillard, Bruno Reversade
Format: Article
Language:English
Published: Springer Nature 2023-04-01
Series:EMBO Molecular Medicine
Subjects:
Online Access:https://doi.org/10.15252/emmm.202217078
_version_ 1826983420061810688
author Samantha Wong
Yu Xuan Tan
Abigail Yi Ting Loh
Kiat Yi Tan
Hane Lee
Zainab Aziz
Stanley F Nelson
Engin Özkan
Hülya Kayserili
Nathalie Escande‐Beillard
Bruno Reversade
author_facet Samantha Wong
Yu Xuan Tan
Abigail Yi Ting Loh
Kiat Yi Tan
Hane Lee
Zainab Aziz
Stanley F Nelson
Engin Özkan
Hülya Kayserili
Nathalie Escande‐Beillard
Bruno Reversade
author_sort Samantha Wong
collection DOAJ
description Abstract Somatic and germline gain‐of‐function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor‐prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss‐of‐function of the proto‐oncogene RAF1 (a.k.a. CRAF). In a consanguineous family, we uncovered a homozygous p.Thr543Met variant segregating with a neonatal lethal syndrome with cutaneous, craniofacial, cardiac, and limb anomalies. Structure‐based prediction and functional tests using human knock‐in cells showed that threonine 543 is essential to: (i) ensure RAF1's stability and phosphorylation, (ii) maintain its kinase activity toward substrates of the MAPK pathway, and (iii) protect from stress‐induced apoptosis mediated by ASK1. In Xenopus embryos, mutant RAF1T543M failed to phenocopy the effects of normal and overactive FGF/MAPK signaling, confirming its hypomorphic activity. Collectively, our data disclose the genetic and molecular etiology of a novel lethal syndrome with progeroid features, highlighting the importance of RTK signaling for human development and homeostasis.
first_indexed 2024-03-07T16:55:38Z
format Article
id doaj.art-12fc7fb5e634482b982be6cd3b0c8a2c
institution Directory Open Access Journal
issn 1757-4676
1757-4684
language English
last_indexed 2025-02-18T06:36:44Z
publishDate 2023-04-01
publisher Springer Nature
record_format Article
series EMBO Molecular Medicine
spelling doaj.art-12fc7fb5e634482b982be6cd3b0c8a2c2024-11-10T12:37:39ZengSpringer NatureEMBO Molecular Medicine1757-46761757-46842023-04-0115511510.15252/emmm.202217078RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesisSamantha Wong0Yu Xuan Tan1Abigail Yi Ting Loh2Kiat Yi Tan3Hane Lee4Zainab Aziz5Stanley F Nelson6Engin Özkan7Hülya Kayserili8Nathalie Escande‐Beillard9Bruno Reversade10Institute of Molecular and Cellular Biology, A*STARInstitute of Molecular and Cellular Biology, A*STARInstitute of Molecular and Cellular Biology, A*STARInstitute of Molecular and Cellular Biology, A*STARDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los AngelesDepartment of Biochemistry and Molecular Biology, The University of ChicagoDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los AngelesDepartment of Biochemistry and Molecular Biology, The University of ChicagoDepartment of Medical Genetics, Koç University, School of MedicineInstitute of Molecular and Cellular Biology, A*STARInstitute of Molecular and Cellular Biology, A*STARAbstract Somatic and germline gain‐of‐function point mutations in RAF, one of the first oncogenes to be discovered in humans, delineate a group of tumor‐prone syndromes known as the RASopathies. In this study, we document the first human phenotype resulting from the germline loss‐of‐function of the proto‐oncogene RAF1 (a.k.a. CRAF). In a consanguineous family, we uncovered a homozygous p.Thr543Met variant segregating with a neonatal lethal syndrome with cutaneous, craniofacial, cardiac, and limb anomalies. Structure‐based prediction and functional tests using human knock‐in cells showed that threonine 543 is essential to: (i) ensure RAF1's stability and phosphorylation, (ii) maintain its kinase activity toward substrates of the MAPK pathway, and (iii) protect from stress‐induced apoptosis mediated by ASK1. In Xenopus embryos, mutant RAF1T543M failed to phenocopy the effects of normal and overactive FGF/MAPK signaling, confirming its hypomorphic activity. Collectively, our data disclose the genetic and molecular etiology of a novel lethal syndrome with progeroid features, highlighting the importance of RTK signaling for human development and homeostasis.https://doi.org/10.15252/emmm.202217078ASK1ERKRAF1RASopathyXenopus
spellingShingle Samantha Wong
Yu Xuan Tan
Abigail Yi Ting Loh
Kiat Yi Tan
Hane Lee
Zainab Aziz
Stanley F Nelson
Engin Özkan
Hülya Kayserili
Nathalie Escande‐Beillard
Bruno Reversade
RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
EMBO Molecular Medicine
ASK1
ERK
RAF1
RASopathy
Xenopus
title RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
title_full RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
title_fullStr RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
title_full_unstemmed RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
title_short RAF1 deficiency causes a lethal syndrome that underscores RTK signaling during embryogenesis
title_sort raf1 deficiency causes a lethal syndrome that underscores rtk signaling during embryogenesis
topic ASK1
ERK
RAF1
RASopathy
Xenopus
url https://doi.org/10.15252/emmm.202217078
work_keys_str_mv AT samanthawong raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT yuxuantan raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT abigailyitingloh raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT kiatyitan raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT hanelee raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT zainabaziz raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT stanleyfnelson raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT enginozkan raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT hulyakayserili raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT nathalieescandebeillard raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis
AT brunoreversade raf1deficiencycausesalethalsyndromethatunderscoresrtksignalingduringembryogenesis